SOX4 and retinoblastoma: Immunoreactivity analysis revealed that SOX4 was predominantly localized in the cell nucleus, with 20 samples classified as high SOX4-expression (42.6%) and 27 samples as low SOX4-expression (57.4%) RB tumors.